Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.
about
Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practiceLeptomeningeal metastasis in breast cancer - a systematic reviewRecent Advancements of Treatment for Leptomeningeal CarcinomatosisImpact of multimodality approach for patients with leptomeningeal metastases from solid tumorsLeptomeningeal carcinomatosis of gastric cancer misdiagnosed as vestibular schwannoma.Leptomeningeal metastases in breast cancer.Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic FactorsDiagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis.Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study.Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.Leptomeningeal carcinomatosis associated with gastric cancer.An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments.
P2860
Q21134093-4E925389-12E9-405C-8DFA-589327FB9792Q26778946-E44B0632-5D2E-4393-BB9B-E28F4F388A54Q26798009-86B70082-AA75-41B2-B842-AD705BD717D1Q34029965-B9883E57-F2CB-428D-AA70-CDFC92DC6DBBQ34289786-431C34FF-72C5-4527-BBCC-178EE91FA6BDQ34650605-DEE85034-4159-4BAD-BCC3-B3510A39A30DQ35633814-867A40DA-232B-40E6-9A3D-B48C6DB166F7Q37409891-A9CE4DF4-F8EC-4BED-B5D2-C9817B0D6C23Q43621058-F2FF3022-2043-4384-A797-347DE7C9D5D1Q44502804-01B9ECC4-B24E-464B-AFA2-3C96A80CCEC2Q48112036-79561418-812E-4872-8FEF-54684F982A54Q48675213-805FD124-264E-4942-B203-36F6E90FE451Q48946369-D42EC029-6A02-4465-927F-2648331080BEQ53282846-CA1009F8-6DE4-4D00-B7AA-02C766600E99Q55327976-2FE6B91F-12A3-4286-B316-2E4F3A0EB0D3
P2860
Leptomeningeal carcinomatosis: prognostic implications of clinical and cerebrospinal fluid features.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@en
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@nl
type
label
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@en
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@nl
prefLabel
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@en
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@nl
P2093
P2860
P356
P1433
P1476
Leptomeningeal carcinomatosis: ...... cerebrospinal fluid features.
@en
P2093
Júlia Miró
Laura González
Miguel Gil
Neuro-Oncology Unit of the Institute of Biomedical Investigation of Bellvitge
Roser Velasco
P2860
P304
P356
10.1002/CNCR.24041
P407
P577
2009-01-01T00:00:00Z